Report Overview

Global Infectious Disease Treatments Market Forecast and Trends

Increasing prevalence of infectious ailments, rising expenditure to boost the penetration rate of treatments of these infections, growing initiatives for creating awareness about treatments & diagnosis of these conditions, and increasing clinical trial studies for the development of new drugs are expected to be the factors responsible for the growth of this market.

Global Infectious Disease Treatments Market: Overview

Infectious diseases are the kind of disorders caused by various organisms, such as viruses, bacteria, fungi, or parasites. The organism can be harmful or essential to the human body, and under some conditions, the organism causes various diseases. These diseases can be transferred from person to person, bites of insects and animals, through the ingestion of contaminated food or water or being exposed to organisms in the environment. Signs and symptoms such as fatigue, fever, others may vary depending on the type of organism caused the infection. Mild infection can be treated through prescribed medicines by physicians, while life-threatening diseases may need hospitalization and extra care.

Growth drivers

Growing prevalence of Infectious Disease

Infection control is especially crucial within healthcare settings, where the risk of infection and disease to patients has dramatically increased. An understanding of the infection process could lead to appropriate actions that help to protect patients and healthcare workers. Proper infection control techniques selected during patient care can help significantly in preventing or reducing avoidable hospital-acquired infections. There are significant public health issues in the prevention and control of infection, including the general health and nutritional status of the public, and their living conditions, such as water, housing, and sanitation facilities. These influence the level of infectious disease in the area, which in turn affects the level of infection of those both in and outside of hospitals, thus affecting the load on healthcare facilities.

Global Infectious Disease Treatments Market: Disease Type

Based on Disease Type, the global Infectious Disease Treatments market segmented into Bacterial Disease, Viral Disease, Fungal Disease and Parasitic Disease.

Global Infectious Disease Treatments Market: Treatment Type

Based on the Treatment type, the global Infectious Disease Treatments market segmented into Antibacterial, Antifungal, Antiviral, Antiparasitic and Alternative Medicine.

Global Infectious Disease Treatments Market: Diagnosis Type

Based on the Diagnosis type, the global Infectious Disease Treatments market segmented into Laboratory Test, Imaging Scans, and Biopsies.

Global Infectious Disease Treatments Market: End-Use

Based on the End-Use, the global Infectious Disease Treatments market segmented into Hospitals, Clinics, Pharmacy Store, Pathology Centre and Others.

Global Infectious Disease Treatments Market: Regional Insights

Based on region, the global Infectious Disease Treatments market segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Rising prevalence of such disorders and favorable reimbursement scenario are key factors likely to propel the demand for infectious disease treatment market in the region. Moreover, the presence of a large number of manufacturers in the U.S. and increasing numbers of clinical trials for the advancement of new treatment drugs are anticipated to contribute to the large market portion held by this region. Major factors that are likely to drive the growth of this market include the growing rate of treatment & diagnosis of infectious diseases and increasing funding activities to support the advancement of new drugs in the region. 

Competitive Landscape

The leading companies of Infectious Disease Treatments Market are Janssen Global Services, Auritec Pharmaceuticals, Pfizer, F. Hoffmann-La Roche, Novartis, Merck, GlaxoSmithKline Pharmaceutical, Ionis Pharmaceuticals, Achillion Pharmaceuticals, Gilead Sciences and other prominent players.

Recent Development

Ø  February, 2020: The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of DARZALEX® (daratumumab) in combination with Kyprolis® (carfilzomib) and dexamethasone (DKd) for relapsed/refractory multiple myeloma. The sBLA is supported by results from the Phase 3 CANDOR study, which compared treatment with DKd to carfilzomib and dexamethasone (Kd) in patients with multiple myeloma who relapsed after one to three prior lines of therapy.

Ø  February, 2020: Merck known as MSD outside the United States and Canada, announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for an update to the prescribing information for BELSOMRA® (suvorexant) C-IV to include findings on its use for the treatment of insomnia in patients with mild-to-moderate Alzheimer’s disease. BELSOMRA is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.

Scope of the Report

By Disease Type

Ø  Bacterial Disease

Ø  Viral Disease

Ø  Fungal Disease

Ø  Parasitic Disease

By Treatment Type

Ø  Antibacterial

Ø  Antifungal

Ø  Antiviral

Ø  Antiparasitic

Ø  Alternative Medicine

By Diagnosis Type

Ø  Laboratory Test

Ø  Imaging Scans

Ø  Biopsies

By End User

Ø  Hospitals

Ø  Diagnostic Laboratories

Ø  Clinics

Ø  Research Laboratories

Ø  Others

By Region:  

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa

The objective of the Study:

Ø  To analyze and forecast the global Infectious Disease Treatments Market size of the market in terms of value.

Ø  To examine the careful market segmentation and forecast the market size, in terms of value, based on the region by segmenting.

Ø  The Global Infectious Disease Treatments Market segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa and their leading countries.

Ø  To outline, categorized, and forecast the global Infectious Disease Treatments Market based on the disease type, treatment type, diagnosis type, and end-user.

Ø  To examine competitive developments like technological advancement, services, and regulative framework within the global Infectious Disease Treatments Market.

Ø  To highlight the impact analysis of the factors affecting the market dynamics such as drivers, restraints, opportunities, and challenges.

Ø  To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.